S. Callahan

Impact of Body Mass Index on Immunogenicity of Pandemic H 1 N 1 Vaccine in Children and Adults

K. Edwards, H. Hill, S. Callahan, 2014 .

Seroprevalence of cytomegalovirus (CMV) and risk factors for infection in adolescent males.

D. Bernstein, K. Edwards, L. Stanberry, 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Impact of body mass index on immunogenicity of pandemic H1N1 vaccine in children and adults.

K. Schmader, M. Mulligan, W. Keitel, 2014, The Journal of infectious diseases.

Assessment of parental acceptance of a potential cytomegalovirus vaccine for adolescent females.

Qingxia Chen, K. Edwards, A. Dempsey, 2010, Vaccine.

Caregiver and adolescent factors associated with delayed completion of the three-dose human papillomavirus vaccination series.

Andrea A. Berry, D. Bernstein, M. Mulligan, 2018, Vaccine.

Safety and efficacy of a cytomegalovirus glycoprotein B (gB) vaccine in adolescent girls: A randomized clinical trial.

D. Bernstein, Shital M. Patel, K. Edwards, 2016, Vaccine.

Seroprevalence and Risk Factors for Cytomegalovirus Infections in Adolescent Females.

D. Bernstein, Shital M. Patel, Gina Simone, 2013, Journal of the Pediatric Infectious Diseases Society.

Antibody responses among adolescent females receiving two or three quadrivalent human papillomavirus vaccine doses at standard and prolonged intervals.

Andrea A. Berry, D. Bernstein, M. Mulligan, 2018, Vaccine.